Coloplast AS (COLO B):企業の財務・戦略的SWOT分析

◆英語タイトル:Coloplast AS (COLO B) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1297
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥14,375見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥28,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥43,125見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Coloplast AS (COLO B) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Coloplast A/S (Coloplast) manufactures and sells products and offers services for ostomy care, urology care, continence care, and skin and wound care. Its major products include ostomy bags; urisheaths; urine bags; catheters; anal irrigation systems; vaginal sling products; advanced foam dressings and hydrocolloid dressings for infected, non-infected and painful wounds; cleansers; moisturizers; skin protectants; anti-fungals; and hand cleansers. It also offers a wide range of disposable products to support endourological and percutaneous procedures, prostate disorders, laparoscopic procedures, and testicular prosthesis. Coloplast supplies its products through subsidiaries and distributors to hospitals, institutions, wholesalers and retailers in Europe, Asia-Pacific and North America. Coloplast is headquartered in Humlebaek, Denmark.

Coloplast AS Key Recent Developments

Mar 18,2020: Coloplast – Announcement no. 03/2020 – Revised Guidance
Mar 18,2020: Coloplast revises full-year organic growth and EBIT margin guidance for 2019/20
Feb 24,2020: Others : Coloplast A/S – Trading in Coloplast shares by board members, executives or associated persons
Feb 21,2020: Others : Coloplast A/S – Selskabsmeddelelse nr. 02/2020 – Aktietilbagekøbsprogram
Feb 21,2020: Coloplast – Announcement no. 2/2020 – share buyback programme

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Coloplast A/S – Key Facts
Coloplast A/S – Key Employees
Coloplast A/S – Key Employee Biographies
Coloplast A/S – Major Products and Services
Coloplast A/S – History
Coloplast A/S – Company Statement
Coloplast A/S – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Coloplast A/S – Business Description
Business Segment: Chronic Care
Overview
Performance
Business Segment: Interventional Urology
Overview
Performance
Business Segment: Wound & Skin Care
Overview
Performance
Geographical Segment: Emerging Markets
Performance
Geographical Segment: European Markets
Target Markets
Performance
Geographical Segment: Other Developed Markets
Performance
R&D Overview
Coloplast A/S – Corporate Strategy
Coloplast A/S – SWOT Analysis
SWOT Analysis – Overview
Coloplast A/S – Strengths
Coloplast A/S – Weaknesses
Coloplast A/S – Opportunities
Coloplast A/S – Threats
Coloplast A/S – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Coloplast A/S, Medical Equipment, Deals By Year, 2014 to YTD 2020
Coloplast A/S, Medical Equipment, Deals By Type, 2014 to YTD 2020
Coloplast A/S, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 21, 2020: Coloplast – Announcement no. 2/2020 – share buyback programme
Feb 06, 2020: Coloplast: Interim financial report, Q1 2019/20
Nov 05, 2019: Coloplast delivers a strong full-year result and the company concludes that the interventional urology business remains core to its future value creation
Nov 05, 2019: Coloplast announced its full-year financial results 2018/19
Jul 01, 2019: The French Ministry of Health has announced a price reform within Ostomy Care, Continence Care and Wound Care
May 02, 2019: Coloplast: Interim financial report, H1 2018/19
May 02, 2019: Coloplast continues solid performance in Q2 and raises expectation for reported growth in DKK
Feb 25, 2019: Coloplast awarded general urological products agreement with Premier
Feb 05, 2019: Coloplast delivers solid start to the year with 8% organic growth
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Coloplast A/S, Key Facts
Coloplast A/S, Key Employees
Coloplast A/S, Key Employee Biographies
Coloplast A/S, Major Products and Services
Coloplast A/S, History
Coloplast A/S, Other Locations
Coloplast A/S, Subsidiaries
Coloplast A/S, Key Competitors
Coloplast A/S, Ratios based on current share price
Coloplast A/S, Annual Ratios
Coloplast A/S, Annual Ratios (Cont...1)
Coloplast A/S, Annual Ratios (Cont...2)
Coloplast A/S, Interim Ratios
Coloplast A/S, Medical Equipment, Deals By Year, 2014 to YTD 2020
Coloplast A/S, Medical Equipment, Deals By Type, 2014 to YTD 2020
Coloplast A/S, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Coloplast A/S, Performance Chart (2015 - 2019)
Coloplast A/S, Ratio Charts
Coloplast A/S, Medical Equipment, Deals By Year, 2014 to YTD 2020
Coloplast A/S, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Coloplast AS (COLO B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Adamas Pharmaceuticals Inc (ADMS):製薬・医療:M&Aディール及び事業提携情報
    Summary Adamas Pharmaceuticals Inc (Adamas Pharmaceuticals) is a pharmaceutical company that develops and commercializes therapeutics for chronic disorders of the central nervous system. The company's Gocovri, formerly ADS-5102, is an amantadine extended-release (XR) formulation for the treatment fo …
  • Senzime AB (SEZI):医療機器:M&Aディール及び事業提携情報
    Summary Senzime AB (Senzime) is a medical device company that develops patient-oriented monitoring systems. The company's product include TetraGraph monitor, CliniSenz analyzer, and Onzurf probe. Its TetraGraph monitor stimulates, measures, analyzes and displays muscle function in surgical patients …
  • VisionCare Inc-医療機器分野:企業M&A・提携分析
    Summary VisionCare Inc (VisionCare) is a medical device company that researches, develops, manufactures, and markets proprietary implantable ophthalmic devices and technologies for the treatment of retinal disorders. The company offers implantable miniature telescope, an implantable medical device t …
  • Daniel Thwaites Plc:企業の戦略・SWOT・財務情報
    Daniel Thwaites Plc - Strategy, SWOT and Corporate Finance Report Summary Daniel Thwaites Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Tyson Foods Inc:戦略・SWOT・企業財務分析
    Tyson Foods Inc - Strategy, SWOT and Corporate Finance Report Summary Tyson Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Mckesson Europe AG.:企業の戦略・SWOT・財務情報
    Mckesson Europe AG. - Strategy, SWOT and Corporate Finance Report Summary Mckesson Europe AG. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cosumar SA:企業の戦略・SWOT・財務分析
    Cosumar SA - Strategy, SWOT and Corporate Finance Report Summary Cosumar SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Auswide Bank Ltd (ABA):企業の財務・戦略的SWOT分析
    Auswide Bank Ltd (ABA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • GIZEH Raucherbedarf GmbH:企業の戦略的SWOT分析
    GIZEH Raucherbedarf GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Eindec Corporation Ltd (42Z):企業の財務・戦略的SWOT分析
    Eindec Corporation Ltd (42Z) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Georgian Oil and Gas Corp:電力:M&Aディール及び事業提携情報
    Summary Georgian Oil and Gas Corp (GOGC) is an oil and gas corporation that explores, produces, transports, and supplies oil and gas products. The corporation offers services such as oil and gas transportation infrastructure operation, oil and gas pipelines design and construction, pipeline developm …
  • Sempra Energy (SRE):電力:M&Aディール及び事業提携情報
    Summary Sempra Energy (Sempra) is an energy-services holding company. Through its subsidiaries, the company invests in, develops, and operates energy infrastructure. It carries out utility operations, development of energy infrastructure and related services in countries including the US, Mexico, Ar …
  • Wolters Kluwer nv:企業の戦略・SWOT・財務情報
    Wolters Kluwer nv - Strategy, SWOT and Corporate Finance Report Summary Wolters Kluwer nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • MYnd Analytics Inc (MYAN)-医療機器分野:企業M&A・提携分析
    Summary MYnd Analytics Inc (MYnd), formerly CNS Response Inc is a biotechnology company that offers medication development programs. The company performs analysis and research, and develops medication for individual patients suffering from mental health and other issues. It provides an PEER Online, …
  • Integer Holdings Corp (ITGR)-医療機器分野:企業M&A・提携分析
    Summary Integer Holdings Corp (Integrated Holdings), formerly Greatbatch Inc is a medical device outsource manufacturer that designs and develops medical devices and power solutions for the medical and non-medical markets. The company offers products such as arthroscopic devices and components, lapa …
  • Urstadt Biddle Properties Inc:企業の戦略・SWOT・財務分析
    Urstadt Biddle Properties Inc - Strategy, SWOT and Corporate Finance Report Summary Urstadt Biddle Properties Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • AltaGas Ltd.:企業の戦略・SWOT・財務分析
    AltaGas Ltd. - Strategy, SWOT and Corporate Finance Report Summary AltaGas Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Southwestern Electric Power Co:企業の戦略的SWOT分析
    Southwestern Electric Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Young Innovations Inc:企業の戦略的SWOT分析
    Young Innovations Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Reliance Communications Ltd (RCOM):企業の財務・戦略的SWOT分析
    Reliance Communications Ltd (RCOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆